We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STRT:NASDAQSTRATTEC SECURITY CORPORATION Analysis

Data as of 2026-09-01 - not real-time

$70.14

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Strattec Security Corporation is neutral at $70.14, with no clear ordering between short and long averages. Over a rolling month the price has lost 14.8%. RSI sits at 28.3, which reads as oversold, and MACD momentum is bearish. The recent range runs from support at $68.18 up to resistance at $93.00.
On valuation the read is undervalued — an earnings multiple of 14.0, absent a reliable peer benchmark. Consensus targets land 21.2% above where the shares trade now.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 40.5%, a beta of 1.10 and a maximum drawdown of 31.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top Market Events

Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q2 2026 investor...Yahoo Finance1monStrattec Security STRT : Insider Buy Signals Undemanding ValuationThe above button links to Coinbase.Morningstar%2c Inc.20dStrattec Announces Fiscal 2026 & Fourth Quarter Financial Results Conference Call and...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 28.3 signals oversold conditions
  • Trading below the 200-day average of 79.02
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 28.3 signals oversold conditions
  • Trading below the 200-day average of 79.02
  • Analyst targets imply +21.2% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +21.2% versus the current price
  • Revenue contracting at -0.1%
  • P/E ratio of 14.0

Key Metrics & Analysis

Financial Health

Revenue Growth-0.10%
Profit Margin3.56%
P/E Ratio14.0
ROE8.45%
ROA4.13%
Debt/Equity0.93
P/B Ratio1.2
Op. Cash Flow$46.3M
Free Cash Flow$27.1M

Technical Analysis

TrendNeutral
RSI28.3
Support$68.18
Resistance$93.00
MA 20$81.27
MA 50$81.87
MA 200$79.02
MACDBearish
VolumeIncreasing
Fear & Greed Index94.79

Valuation

Fair Value$113.23
Target Price$85.00
Upside/Downside21.19%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.10
Volatility40.45%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.